Earnings Snapshot: AbbVie Q4 top-line beats estimates; 2025 EPS outlook beat expectations
by
Contributor since / Followers
Contributor since / Followers
2 months ago
*Other Operating Data Consensus Source: Bloomberg
More on AbbVie:
-
AbbVie Non-GAAP EPS of $2.16 misses by $0.10, revenue of $15.1B beats by $270M
-
AbbVie in charts: Revenues from Humira -49%, Skyrizi +57.8%, Rinvoq +46% Y/Y
- AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine
- Top 4 Immunology Stocks Poised For Growth In 2025
- Allergan Aesthetics launches new AA signature program at IMCAS 2025